AMITESH PANDA

Mr. AMITESH PANDA

PhD Student
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
13 June 2022 in Nature Cell Biology
Verified
Journal Article
Open access
PDF file
DZDick W. Zijlmans
Dick W. Zijlmans
ITIrene Talon
Irene Talon
SVSigrid Verhelst
Sigrid Verhelst
ABAdam Bendall
Adam Bendall
KNKarlien Van Nerum
Karlien Van Nerum
Vincent PasqueVincent Pasque
Vincent Pasque
Human naive pluripotent stem cells have unrestricted lineage potential. Underpinning this property, naive cells are thought to lack chromatin-based lineage barriers. However, this assumption has not been tested. Here we define the chromatin-associated proteome, histone post-translational modifications and transcriptome of human naive and primed pluripotent stem cells. Our integrated analysis reveals differences in the relative abundance and activities of distinct chromatin modules. We identify a strong enrichment of polycomb repressive complex 2 (PRC2)-associated H3K27me3 in the chromatin of naive pluripotent stem cells and H3K27me3 enrichment at promoters of lineage-determining genes, including trophoblast regulators. PRC2 activity acts as a chromatin barrier restricting the differentiation of naive cells towards the trophoblast lineage, whereas inhibition of PRC2 promotes trophoblast-fate induction and cavity formation in human blastoids. Together, our results establish that human naive pluripotent stem cells are not epigenetically unrestricted, but instead possess chromatin mechanisms that oppose the induction of alternative cell fates.

17 December 2020 in Cells
Verified
Journal Article
Open access
PDF file
AMITESH PANDAAMITESH PANDA
AMITESH PANDA
Jan ZyliczJan Zylicz
Jan Zylicz
Vincent PasqueVincent Pasque
Vincent Pasque
Dosage compensation between the sexes results in one X chromosome being inactivated during female mammalian development. Chromosome-wide transcriptional silencing from the inactive X chromosome (Xi) in mammalian cells is erased in a process termed X-chromosome reactivation (XCR), which has emerged as a paradigm for studying the reversal of chromatin silencing. XCR is linked with germline development and induction of naive pluripotency in the epiblast, and also takes place upon reprogramming somatic cells to induced pluripotency. XCR depends on silencing of the long non-coding RNA (lncRNA) X inactive specific transcript (Xist) and is linked with the erasure of chromatin silencing. Over the past years, the advent of transcriptomics and epigenomics has provided new insights into the transcriptional and chromatin dynamics with which XCR takes place. However, multiple questions remain unanswered about how chromatin and transcription related processes enable XCR. Here, we review recent work on establishing the transcriptional and chromatin kinetics of XCR, as well as discuss a model by which transcription factors mediate XCR not only via Xist repression, but also by direct targeting of X-linked genes.

1 March 2025 in Development
Verified
Journal Article
Closed access
ENEliana Nehme
Eliana Nehme
AMITESH PANDAAMITESH PANDA
AMITESH PANDA
IMIsabelle Migeotte
Isabelle Migeotte
Vincent PasqueVincent Pasque
Vincent Pasque
Extra-embryonic tissues provide protection and nutrition in vertebrates, as well as a connection to the maternal tissues in mammals. The extra-embryonic mesoderm is an essential and understudied germ layer present in amniotes. It is involved in hematopoiesis, as well as in the formation of extra-embryonic structures such as the amnion, umbilical cord and placenta. The origin and specification of extra-embryonic mesoderm are not entirely conserved across species, and the molecular mechanisms governing its formation and function are not fully understood. This Review begins with an overview of the embryonic origin and function of extra-embryonic mesoderm in vertebrates from in vivo studies. We then compare in vitro models that generate extra-embryonic mesoderm-like cells. Finally, we discuss how insights from studying both embryos and in vitro systems can aid in designing even more advanced stem cell-based embryo models.

19 November 2025 in bioRxiv
Verified
Preprint
Open access
AMITESH PANDAAMITESH PANDA
AMITESH PANDA
LCLeo Carrillo
Leo Carrillo
BBBradley Philip Balaton
Bradley Philip Balaton
JBJeanne Brouillet
Jeanne Brouillet
SNSolomon Nshemereirwe
Solomon Nshemereirwe
Vincent PasqueVincent Pasque
Vincent Pasque
Dosage compensation of sex chromosomes through X-chromosome inactivation (XCI) is required for mice extra-embryonic tissue growth and embryo development. The species specificity in mechanisms and timing leading to XCI during early embryogenesis, however, left the key question of the interdependence between XCI and human development open. Here, we show that the differentiation of naive human pluripotent stem cells to trophoblast stem cells and extraembryonic mesoderm cells triggers XCI. The inactive X chromosome, however, displays an atypical chromatin state, lacking classical enrichment of heterochromatin markers and DNA methylation. We demonstrate that extraembryonic differentiation and XCI are kinetically and functionally linked. Using loss of function approaches, we prove that XIST is required for human XCI establishment. We also reveal that XCI is key for the survival of human female extraembryonic cells. Our work therefore links XCI to the formation of extraembryonic annexes, with important consequences for human reproductive biology.

22 October 2026 in Nature Communications
Verified
Journal Article
Open access
PDF file
AMITESH PANDAAMITESH PANDA
AMITESH PANDA
LCLéo Carrillo
Léo Carrillo
BBBradley Philip Balaton
Bradley Philip Balaton
JBJeanne Brouillet
Jeanne Brouillet
SNSolomon Nshemereirwe
Solomon Nshemereirwe
Vincent PasqueVincent Pasque
Vincent Pasque
X-chromosome inactivation (XCI) is essential for extraembryonic tissue growth and embryo development in mice. However, species-specific differences in its timing and regulation have left its role in human development unclear. Here, we show that the in vitro differentiation of naive human pluripotent stem cells to trophoblast stem cells and extraembryonic mesoderm cells is accompanied by XCI. The inactive X chromosome displays an atypical chromatin state, lacking DNA methylation and canonical heterochromatin marks. We demonstrate that extraembryonic differentiation and XCI are temporally linked. Using loss of function approaches, we found that XIST is required for XCI establishment in humans. Furthermore, we show that XCI is needed for the survival of human female extraembryonic cells. Together, these findings link XCI to the formation of human extraembryonic lineages, with important implications for human reproductive biology.

29 July 2024 in Research Square
Verified
Preprint
Open access
PDF file
KCKatrien De Clercq
Katrien De Clercq
VPVicente Perez-Garcia
Vicente Perez-Garcia
AMITESH PANDAAMITESH PANDA
AMITESH PANDA
JLJorge López-Tello
Jorge López-Tello
KMKatarzyna Maksym
Katarzyna Maksym
JVJoris Vriens
Joris Vriens
TRPV2 is a calcium-permeable ion channel with a broad expression pattern that contributes to neuronal outgrowth, immune response, and cardiac function. Mice lacking Trpv2 are more susceptible to perinatal lethality, a phenotype that cannot be explained by its previously allocated functions. We recently reported functional TRPV2 expression in mouse trophoblast cells and described temporal expression changes during placental development in mice. Here, we provide compelling evidence that TRPV2 plays a vital role in normal placental development, determining fetal size and survival. Specifically, Trpv2 is abundantly present in a subset of murine placental syncytiotrophoblast cells II (SynTII) during early development. Its absence results in region-specific loss of SynTII cells and fetal vascular invasion, severely affecting placental morphology. Consequently, global Trpv2 knockout mice suffer from fetal growth restriction and embryonic lethality, a phenotype found to be allocated to a non-redundant role in the trophoblast, but not in the embryo. CRISPR/Cas9-mediated Trpv2 deletion in mouse trophoblast stem cells identified a critical role of Trpv2 in the differentiation process towards SynTII cells, which was confirmed by the growth restriction phenotype in SynTII-specific Trpv2 knockout animals. TRPV2 expression was abundantly detected in human syncytiotrophoblast cells differentiated from trophoblast stem cells, suggesting a conserved role for TRPV2 in human trophoblast differentiation. Finally in the human placenta, TRPV2 expression was lower in early-onset fetal growth restriction compared to appropriately grown pregnancies. Taken together, our findings identify for the first time the indispensable role of TRPV2 during placental development, arbitrating fetal outcomes.